Literature DB >> 16849646

MicroRNAs modulate the angiogenic properties of HUVECs.

Laura Poliseno1, Andrea Tuccoli, Laura Mariani, Monica Evangelista, Lorenzo Citti, Keith Woods, Alberto Mercatanti, Scott Hammond, Giuseppe Rainaldi.   

Abstract

MicroRNAs (miRNAs) have recently come into focus as key posttranscriptional modulators of gene expression. In this work, we addressed whether in vitro angiogenesis is an miRNA-regulated process. We performed large-scale analysis of miRNA expression in human umbilical vein endothelial cells (HUVECs) and found that 15 highly expressed miRNAs have the receptors of angiogenic factors as putative targets. In particular, we demonstrated that miR-221 and miR-222 affect c-Kit expression and, as a consequence, the angiogenic properties of its ligand stem cell factor. Interaction between miR-222 and c-Kit is likely to be part of a complex circuit that controls the ability of endothelial cells to form new capillaries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16849646     DOI: 10.1182/blood-2006-01-012369

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  306 in total

1.  Cell-specific effects of miR-221/222 in vessels: molecular mechanism and therapeutic application.

Authors:  Xiaojun Liu; Yunhui Cheng; Jian Yang; Ling Xu; Chunxiang Zhang
Journal:  J Mol Cell Cardiol       Date:  2011-11-22       Impact factor: 5.000

2.  miR-221 is required for endothelial tip cell behaviors during vascular development.

Authors:  Stefania Nicoli; Carl-Philipp Knyphausen; Lihua J Zhu; Abirami Lakshmanan; Nathan D Lawson
Journal:  Dev Cell       Date:  2012-02-14       Impact factor: 12.270

Review 3.  Role of microRNAs in endothelial inflammation and senescence.

Authors:  Bing Qin; Huan Yang; Bo Xiao
Journal:  Mol Biol Rep       Date:  2011-09-28       Impact factor: 2.316

Review 4.  MicroRNA in ischemic stroke etiology and pathology.

Authors:  Cameron Rink; Savita Khanna
Journal:  Physiol Genomics       Date:  2010-09-14       Impact factor: 3.107

5.  miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.

Authors:  Deena M Leslie Pedrioli; Terhi Karpanen; Vasilios Dabouras; Giorgia Jurisic; Glenn van de Hoek; Jay W Shin; Daniela Marino; Roland E Kälin; Sebastian Leidel; Paolo Cinelli; Stefan Schulte-Merker; André W Brändli; Michael Detmar
Journal:  Mol Cell Biol       Date:  2010-05-17       Impact factor: 4.272

Review 6.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

Review 7.  miRNAs: roles and clinical applications in vascular disease.

Authors:  Md Saha Jamaluddin; Sarah M Weakley; Lidong Zhang; Panagiotis Kougias; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Expert Rev Mol Diagn       Date:  2011-01       Impact factor: 5.225

Review 8.  microRNAs: tiny RNA molecules, huge driving forces to move the cell.

Authors:  Shenglin Huang; Xianghuo He
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

Review 9.  microRNAs in cardiovascular development.

Authors:  Jinghai Chen; Da-Zhi Wang
Journal:  J Mol Cell Cardiol       Date:  2012-01-24       Impact factor: 5.000

Review 10.  MicroRNAs in colorectal cancer: role in metastasis and clinical perspectives.

Authors:  Shan Muhammad; Kavanjit Kaur; Rui Huang; Qian Zhang; Paviter Kaur; Hamza Obaid Yazdani; Muhammad Umar Bilal; Jiang Zheng; Liu Zheng; Xi-Shan Wang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.